(Q44593201)

4 December 2017

Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease (English)

1 reference

4 December 2017

0 references

Gulsah Seydaoglu

4

0 references

author name string

Abdullah Canataroglu

1

1 reference

4 December 2017

Kahraman Tanriverdi

2

1 reference

4 December 2017

Tamer Inal

3

1 reference

4 December 2017

Didem Arslan

5

1 reference

4 December 2017

Suleyman Ozbek

6

1 reference

4 December 2017

Fikri Baslamisli

7

1 reference

4 December 2017

language of work or name

1 reference

14 March 2003

1 reference

Rheumatology International

4 December 2017

1 reference

4 December 2017

23

1 reference

4 December 2017

5

1 reference

4 December 2017

236-240

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-003-0301-8

4 December 2017

0 references

cites work

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia

1 reference

12 December 2020

The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.

1 reference

12 December 2020

Homocysteine, B vitamins, and coronary artery disease

1 reference

12 December 2020

Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase

1 reference

12 December 2020

Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis

1 reference

12 December 2020

Behçet syndrome associated with protein S deficiency

1 reference

12 December 2020

Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease

1 reference

12 December 2020

Hyperhomocysteinaemia in Behçet's disease.

1 reference

12 December 2020

Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells

1 reference

12 December 2020

Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency

1 reference

12 December 2020

Coagulation parameters and plasma total homocysteine levels in Behcet's disease

1 reference

12 December 2020

C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients

1 reference

12 December 2020

Risk factors for venous thrombosis: prevalence, risk, and interaction.

1 reference

12 December 2020

Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease

1 reference

12 December 2020

Vascular involvement in Behçet's disease

1 reference

12 December 2020

Homocysteine and cardiovascular disease

1 reference

12 December 2020

The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism

1 reference

12 December 2020

Vascular involvement in Behçet's disease: arterial and venous and vessels of all sizes

1 reference

12 December 2020

Procoagulant mutations and venous thrombosis in Behçet's disease

1 reference

12 December 2020

Pathological haemostasis and "prothrombotic state" in Behçet's disease.

1 reference

12 December 2020

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

12 December 2020

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

12 December 2020

Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease

1 reference

12 December 2020

Hemostatic parameters in Behçet's disease: a reappraisal

1 reference

12 December 2020

Homocysteine and atherothrombosis

1 reference

12 December 2020

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

12 December 2020

Impaired homocysteine metabolism and atherothrombotic disease

1 reference

12 December 2020

10.1007/S00296-003-0301-8

Identifiers

DOI

1 reference

4 December 2017

1 reference